Mainstream

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Post ContentmdtRead More

You might also be interested in reading Dormant No More: 2012 Bitcoin Wallet Moves $35.7M, Linked to Last Month’s Whale Transfers.

August 19, 2025
In Mainstream